Sarepta Therapeutics (SRPT) Times Interest Earned (2017 - 2022)
Sarepta Therapeutics' quarterly Times Interest Earned came in at -$8.41 in Q4 2022, down 27.58% year-on-year from -$11.62 in Q4 2021, and up 5.63% quarter-over-quarter from -$8.91 in Q3 2022.
Sarepta Therapeutics has reported Times Interest Earned for 6 years, with the latest figure at -$8.41 in Q4 2022.
- For the quarter ending Q4 2022, Times Interest Earned fell 27.58% year-over-year to -$8.41; the trailing twelve-month figure through Sep 2023 stood at -$31.44 (down 273.28% YoY), and the FY2023 full-year result was -$12.17, down 20.84% from the prior year.
- Times Interest Earned for Q4 2022 stood at -$8.41, up from -$8.91 in the prior quarter.
- The five-year high for Times Interest Earned was -$1.67 in Q3 2021, with the low at -$444.11 in Q1 2019.
- Average Times Interest Earned over 5 years is -$52.16, with a median of -$10.21 recorded in 2018.
- Year-over-year, Times Interest Earned plunged 10929.44% in 2019 and soared 98.05% in 2020.
- Tracing SRPT's Times Interest Earned over 5 years: stood at -$60.3 in 2018, then surged by 54.5% to -$27.44 in 2019, then surged by 42.15% to -$15.87 in 2020, then jumped by 58.47% to -$6.59 in 2021, then declined by 27.58% to -$8.41 in 2022.
- The last three Times Interest Earned figures came in at -$8.41 (Q4 2022), -$8.91 (Q3 2022), and -$12.45 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -8.41 |
| Sep 30, 2022 | -8.91 |
| Jun 30, 2022 | -12.45 |
| Mar 31, 2022 | -5.50 |
| Dec 31, 2021 | -6.59 |
| Sep 30, 2021 | -1.67 |
| Jun 30, 2021 | -10.35 |
| Mar 31, 2021 | -9.70 |
| Dec 31, 2020 | -15.87 |
| Sep 30, 2020 | -9.56 |
| Jun 30, 2020 | -11.12 |
| Mar 31, 2020 | -8.67 |
| Dec 31, 2019 | -27.44 |
| Sep 30, 2019 | -49.24 |
| Jun 30, 2019 | -319.45 |
| Mar 31, 2019 | -444.11 |
| Dec 31, 2018 | -60.30 |
| Sep 30, 2018 | -10.06 |
| Jun 30, 2018 | -19.82 |
| Mar 31, 2018 | -4.03 |
| Dec 31, 2017 | -5.17 |
| Sep 30, 2017 | -57.24 |
| Jun 30, 2017 | -239.02 |
| Mar 31, 2017 | -152.70 |